“For any treatment, it’s important to not only consider clinical outcomes such as recurrent heart attacks or stroke, but also to consider the effect of the treatment on a patient’s quality of life,” said Suzanne J. Baron, M.D., study investigator and assistant professor of medicine at the University of Missouri-Kansas City. “These data demonstrate that PCI is a reasonable treatment option for patients with left main coronary artery disease that allows them to potentially avoid surgery and to rapidly obtain a better quality of life after revascularization.”
Related Stories
$20 Million Scholarship Article in The Kansas City Star
KC Scholars partnership also in U.S. News and World Report … Read more
Geosciences Professor’s Research Cited in New York Times
Fengpeng Sun co-authored study on California wildfire seasons The 2015 … Read more
Bloch Faculty Interviewed on NBC Nightly News
Brent Never teaches about Kansas City’s racial dividing line Never … Read more